MAPT and Alzheimer disease: Lastly, several nanoscale changes in molecular and cellular structures occur in the brains of people with AD because of the damage and death of neurons throughout the brain, as well as the possible breakdown of connections between networks of neurons caused by abnormal accumulations of tau and beta-amyloid proteins inside and between neurons, leading to increasing structural abnormalities and early mass density fluctuations.